Related Experiment Video
Updated: Jun 7, 2026

08:09
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
MicroRNA array analysis of microRNAs related to systemic scleroderma
Haitao Li1, Rongya Yang, Xin Fan
1Department of Dermatology and Venerology, Beijing Military Command General Hospital of PLA, Beijing 100125, China.
Rheumatology International
|November 6, 2010
Summary
This study identified differentially expressed microRNAs (miRNAs) in systemic scleroderma (SSc) patients, suggesting their role in SSc pathogenesis and potential as diagnostic biomarkers.
Area of Science:
- Molecular Biology
- Genetics
- Immunology
Background:
- MicroRNAs (miRNAs) are crucial noncoding RNA regulators in cellular processes.
- Dysregulation of miRNAs is implicated in the pathogenesis of various human diseases.
- Systemic scleroderma (SSc) is a complex autoimmune disease with poorly understood mechanisms.
Purpose of the Study:
- To investigate the role of microRNAs in the pathogenesis of systemic scleroderma (SSc).
- To compare microRNA profiles between SSc patients and healthy controls.
- To identify potential microRNA biomarkers for SSc diagnosis.
Main Methods:
- Skin tissue samples were obtained from three SSc patients and three healthy controls.
- MicroRNA microarray analysis was performed to identify differentially expressed miRNAs.
- Real-time PCR was used to validate the microarray findings.
Main Results:
- Microarray analysis revealed 24 differentially expressed miRNAs in SSc patients compared to controls.
- Six specific microRNAs were identified as potentially correlated with SSc pathogenesis.
- Real-time PCR confirmed the differential expression patterns observed in the microarray analysis.
Conclusions:
- MicroRNAs are likely involved in the pathogenesis of systemic scleroderma.
- The identified differentially expressed miRNAs may serve as potential diagnostic biomarkers for SSc.
- Further research into miRNA functions could elucidate SSc mechanisms and therapeutic targets.
Related Concept Videos
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
